548 related articles for article (PubMed ID: 30445504)
1. A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.
Chudy-Onwugaje KO; Christian KE; Farraye FA; Cross RK
Inflamm Bowel Dis; 2019 Apr; 25(5):820-830. PubMed ID: 30445504
[TBL] [Abstract][Full Text] [Related]
2. An update on biosimilar drugs for inflammatory bowel disease.
Schreiber S
Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():1-3. PubMed ID: 26395529
[TBL] [Abstract][Full Text] [Related]
3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
4. New drug therapies on the horizon for IBD.
Perrier C; Rutgeerts P
Dig Dis; 2012; 30 Suppl 1():100-5. PubMed ID: 23075877
[TBL] [Abstract][Full Text] [Related]
5. A Practical Guide to the Safety and Monitoring of New IBD Therapies.
Click B; Regueiro M
Inflamm Bowel Dis; 2019 Apr; 25(5):831-842. PubMed ID: 30312391
[TBL] [Abstract][Full Text] [Related]
6. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
Aardoom MA; Veereman G; de Ridder L
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin-Biroulet L
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
[TBL] [Abstract][Full Text] [Related]
8. Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.
Yoon SM; Haritunians T; Chhina S; Liu Z; Yang S; Landers C; Li D; Ye BD; Shih D; Vasiliauskas EA; Ippoliti A; Rabizadeh S; Targan SR; Melmed GY; McGovern DPB
Inflamm Bowel Dis; 2017 Aug; 23(8):1382-1393. PubMed ID: 28590340
[TBL] [Abstract][Full Text] [Related]
9. [Biologics in current therapy for inflammatory bowel disease].
Hisamatsu T; Hibi T
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Jun; 32(3):168-79. PubMed ID: 19564713
[TBL] [Abstract][Full Text] [Related]
10. [Biologic therapies in inflammatory bowel disease: anti-TNF and new therapeutic targets].
Flamant M; Bourreille A
Rev Med Interne; 2007 Dec; 28(12):852-61. PubMed ID: 17628232
[TBL] [Abstract][Full Text] [Related]
11. [TNF-alpha inhibitors in inflammatory bowel disease].
Casellas i Jordà F
Med Clin (Barc); 2004 Nov; 123(16):627-34. PubMed ID: 15546523
[TBL] [Abstract][Full Text] [Related]
12. Perioperative Use of Anti-TNFa Biological Agents in Open and Laparoscopic Surgery for Inflammatory Bowel Disease.
Lianos GD; Katsanos KH; Saridi M; Albani E; Koutroumpakis E; Zeglinas C; Glantzounis GK; Papaconstantinou I; Christodoulou DK
Surg Technol Int; 2019 May; 34():107-114. PubMed ID: 30888671
[TBL] [Abstract][Full Text] [Related]
13. [Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
Stange EF
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S90-S1. PubMed ID: 11930299
[TBL] [Abstract][Full Text] [Related]
14. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
15. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
16. Novel treatments for inflammatory bowel disease.
Lee HS; Park SK; Park DI
Korean J Intern Med; 2018 Jan; 33(1):20-27. PubMed ID: 29223139
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.
El Mourabet M; El-Hachem S; Harrison JR; Binion DG
Curr Drug Targets; 2010 Feb; 11(2):234-41. PubMed ID: 19916950
[TBL] [Abstract][Full Text] [Related]
18. Strategies for targeting tumour necrosis factor in IBD.
Sandborn WJ
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):105-17. PubMed ID: 12617886
[TBL] [Abstract][Full Text] [Related]
19. [New molecules in the treatment of inflammatory bowel disease].
Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2016; 39(6):411-23. PubMed ID: 26631943
[TBL] [Abstract][Full Text] [Related]
20. How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease.
Naviglio S; Giuffrida P; Stocco G; Lenti MV; Ventura A; Corazza GR; Di Sabatino A
Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):797-810. PubMed ID: 29957083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
